Atlantic International Corp. (ATLN) Stock
ATLN Key Statistics
About Atlantic International Corp.
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
CEO: Todd McNulty. Company website
ATLN — Frequently Asked Questions
What is the ATLN stock price today?
Atlantic International Corp. (ATLN) trades at $1.15, up 35.29% on the day, as of Sep 20, 2026 15:01 UTC.
What is Atlantic International Corp.'s market cap?
Atlantic International Corp. has a market capitalisation of $91.26M, calculated from the live ATLN share price and shares outstanding.
What is the P/E ratio of ATLN?
ATLN has no meaningful price-to-earnings ratio: Atlantic International Corp. lost $1.08 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Atlantic International Corp. make?
Atlantic International Corp. generated revenue of $435.88M over the trailing twelve months, which puts the stock at 0.21 times sales.
What is the 52-week range for ATLN?
ATLN has traded between $0.41 and $4.56 over the past 52 weeks, and the last price is 74.8% below that high.
Is Atlantic International Corp. profitable?
No. Atlantic International Corp. is loss-making, with a net margin of -13.63% over the trailing twelve months.
What sector is Atlantic International Corp. in?
Atlantic International Corp. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US .
Who is the CEO of Atlantic International Corp.?
Todd McNulty is the chief executive of Atlantic International Corp., which employs 300 people.
Where can I track ATLN in real time?
QFI Terminal shows ATLN with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ATLN live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ATLN in Terminal See plans